- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Arecor Therapeutics PLC (AREC)
Track today's live Arecor Therapeutics (AREC) share price, performance and key data on this page with our current London:AREC stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Arecor Therapeutics share price on the London exchange. Use the dropdown to switch exchange for the AREC share price, head to our technical summary section, which provides analysis on Arecor Therapeutics share price buy/sell indicators using real-time data (or discuss the Arecor Therapeutics (AREC) stock price today with other investors in the Arecor Therapeutics LON share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current LON:AREC share price (ISIN: GB00BMWLM973) to enhance your trading decisions with our free investment tools and resources.
What Is the Arecor Therapeutics PLC Share Price Today?
The Arecor Therapeutics share price today is 59.50.
What Is the Stock Symbol for Arecor Therapeutics PLC
The stock symbol (or 'ticker') for Arecor Therapeutics PLC is "AREC."
What Stock Exchange Does Arecor Therapeutics PLC Trade On?
Arecor Therapeutics PLC is listed and trades on the London stock exchange.
Is Arecor Therapeutics PLC a Good Stock to Buy?
Determining whether Arecor Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current LON:AREC share price (ISIN: GB00BMWLM973) to enhance your trading decisions with our free investment tools and resources.
What Is the Arecor Therapeutics PLC Share Price Today?
The Arecor Therapeutics share price today is 59.50.
What Is the Stock Symbol for Arecor Therapeutics PLC
The stock symbol (or 'ticker') for Arecor Therapeutics PLC is "AREC."
What Stock Exchange Does Arecor Therapeutics PLC Trade On?
Arecor Therapeutics PLC is listed and trades on the London stock exchange.
Is Arecor Therapeutics PLC a Good Stock to Buy?
Determining whether Arecor Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
London
Currency in GBP
59.50
+1.00(+1.71%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
59.50
62.00
52 wk Range
55.27
100.00
AREC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
59.5062.00
52 wk Range
55.27100.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
AREC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
275.50
Upside
+363.03%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Arecor receives $0.5m milestone from Ligand deal- Investing.com
- Arecor receives $0.5m milestone from Ligand deal
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 275.50
(+363.03% Upside)
Earnings
Latest Release
13/04/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare AREC to Peers and Sector
Metrics to compare | AREC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipARECPeersSector | |
|---|---|---|---|---|
P/E Ratio | 23.7x | −6.3x | −0.4x | |
PEG Ratio | 0.23 | −0.12 | 0.00 | |
Price/Book | 3.4x | 5.4x | 2.6x | |
Price / LTM Sales | 12.9x | 8.8x | 3.1x | |
Upside (Analyst Target) | 370.9% | 163.6% | 48.2% | |
Fair Value Upside | Unlock | −12.2% | 5.8% | Unlock |
Arecor Therapeutics plc, a clinical stage biotechnology company, develops therapeutics that address diabetes, obesity and other cardiometabolic diseases in the United Kingdom. The company’s lead therapeutic product is the AT278, a disruptor insulin which is designed to transform Automated Insulin Delivery (AID) systems to improve patient care for people living with diabetes. It also develops a novel oral delivery platform using a GLP-1 receptor agonist. Arecor Therapeutics plc was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Arecor Therapeutics (London: AREC) Share Price Today?
The Arecor Therapeutics stock price today is 59.50 GBP.
What Stock Exchange Does Arecor Therapeutics (AREC) Trade On?
Arecor Therapeutics is listed and trades on the London Stock Exchange.
What Is the Ticker (Stock Symbol) for Arecor Therapeutics?
The stock symbol (also called a 'ticker') for Arecor Therapeutics is "AREC."
What Is the Current Arecor Therapeutics Market Capitalisation?
As of today, Arecor Therapeutics (London: AREC) market cap is 22.09M GBP.
What Is Arecor Therapeutics's (AREC) Earnings Per Share (TTM)?
The Arecor Therapeutics EPS is currently 0.02 (Trailing Twelve Months).
When Is the Next Arecor Therapeutics Earnings Date?
Arecor Therapeutics's next earnings report will be released on 24/09/2026.
Is AREC a Buy or Sell From a Technical Analyst Perspective?
Based on today's Arecor Therapeutics moving averages and other technical indicators, the daily buy/sell signal for AREC stock is Strong Sell.
How Many Times Has Arecor Therapeutics Stock Split?
Arecor Therapeutics has split 0 times. (See the AREC stock split history page for full effective split date and price information.)
How Many Employees Does Arecor Therapeutics Have?
Arecor Therapeutics has 33 employees, based on their latest Companies House report.
What is the current trading status of Arecor Therapeutics (London: AREC)?
As of 11/08/2026, Arecor Therapeutics (AREC) is trading at a share price of 59.50 GBP, with a previous close of 58.50 GBP. The stock has fluctuated within a day range of 59.50 GBP to 62.00 GBP, while its 52-week range spans from 55.27 GBP to 100.00 GBP.
What Is Arecor Therapeutics (AREC) Price Target According to Analysts?
The average 12-month price target for Arecor Therapeutics is 275.50 GBP, with a high estimate of 300 GBP and a low estimate of 251 GBP. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +363.03% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.